Peter D. Ho
Keine laufenden Positionen mehr
Profil
Peter D.
Ho worked as a Director of Business Development at Iovance Biotherapeutics, Inc. and as Head of Business Development & Licensing at ImmunoCellular Therapeutics Ltd.
He holds a Master's in Business Administration from the University of California, Los Angeles and a doctorate from the University of California San Diego.
Ehemalige bekannte Positionen von Peter D. Ho
| Unternehmen | Position | Ende |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Corporate Officer/Principal | - |
Ausbildung von Peter D. Ho
| University of California, Los Angeles | Masters Business Admin |
| University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology ImmunoCellular Therapeutics, Ltd. is a clinical-stage pharmaceutical company, focused on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis. The company also develops EOM 147, an investigational, broad-spectrum aminosterol with an intracellular mechanism for the treatment of chronic and debilitating retinal diseases. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ. | Health Technology |
